Patent ID: 7842278
Filing Date: 2010-11-30
Classification: A61K,A61P,C07D,C07F

Abstract:
1. A compound having the structure of formula I and pharmaceutically acceptable salts thereof wherein: R1 is a halogen, positron emitting radionuclide, non-metal, lower alkyl substituted to contain a halogen, lower alkyl substituted to contain a positron emitting radionuclide, lower alkyl substituted to contain a non-metal, tosylate, mesylate, tryflate, hydrogen, or hydroxyl; and R2 and R3 are independently selected from a lower alkyl, allyl, alkenyl, alkynyl, hydroxyalkyl, heteroalkyl, polyether, and polyether with a terminal heteroatom and wherein at least one of R2 or R3 comprises a boron cluster and, optionally, a therapeutic agent, cytotoxic agent, detectable label, or chelating group.